Sources FDA Prescribing Information: Zepbound (tirzepatide) January 2026 label New England Journal of Medicine: Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) AJMC: FDA Approves Monthly KwikPen Option for Tirzepatide Drugs.com: Tirzepatide (Zepbound) dosing and safety Eli Lilly: Mounjaro Prescribing Information Medical disclaimer This article is for educational purposes only and does not constitute medical advice
Avoiding industrial vegetable/seed oils such as a canola, sunflower, cottonseed, soybean, grapeseed, rapeseed, mustard, and peanut should be top priority
This is likely because insulin resistance, insulin use, and long-standing metabolic disease can blunt weight-loss responses
Also, if you notice any skin condition changes, contact your doctor
In Rel3 spheroid cells treated with the SU11274 there is also increased expression MUSASHI-1 along with an increase in Nestin, which can be also related to the increased cell motility, invasiveness and malignancy
CHALLENGES Greater Anxiety Around Injections People with diabetes often become familiar with managing complex medication regimens due to the ongoing need for blood glucose control
